Hurone is a health-AI company building the operating layer for continuous cancer care and other complex chronic conditions.
Our platform connects patients and care teams between visits, enabling proactive, risk-aware coordination and measurable outcomes in real-world oncology workflows.
The patient-facing application is called Hurona, powered by Hurone’s predictive and orchestration infrastructure.
Hurona is the user-facing application that patients interact with, powered by Hurone’s enterprise platform.
For patients, Hurona offers 24/7 guidance on symptoms, treatment logistics, social barriers, and trial adherence.
For clinicians, Hurona delivers structured summaries, risk signals, and severity-tagged escalations directly into existing workflows like Epic.
It is not a portal or a chatbot; it is an orchestration layer that drives coordination, action, and measurable impact.
Patient portals are reactive communication tools.
Hurone is proactive, predictive, and execution-oriented:
Hurone is built for enterprise workflows, not just individual communication.
Yes.
Hurone supports integration with wearable devices and home monitoring tools (e.g., heart rate, activity, sleep, remote vitals).
This enriches the patient journey and enables:
These data streams augment, not replace, clinical judgment.
Hurone includes a Clinical Trial Companion that helps sites and sponsors:
Hurone also supports research initiatives at institutional partners by generating structured, de-identified longitudinal data on cancer patient journeys that can inform quality improvement and predictive models.
Oncology is where we began because it represents one of the most complex and fragmented care journeys.
However, Hurone’s architecture is modular and extensible. The same continuous care orchestration model applies to other complex domains such as:
These disease areas share similar challenges: between-visit complexity, social barriers, protocol adherence, and high avoidable utilization.
Hurone’s current deployments and enterprise partnerships are focused on the U.S. market, where mature digital health infrastructure, provider budgets, and value-based care models allow commercial scale.
We initially worked in African health systems early in our history. To understand our pivot and the strategic reasoning behind it, you can read more here:
Why We Pivoted from Africa to the United States.
Hurone is HIPAA-compliant and built with enterprise-grade security:
We do not sell patient data.
No.
Hurone augments clinical teams by:
All clinical decisions remain under the authority of licensed providers.
Hurone supports:
This enables deep workflow integration and reduces manual documentation burden.
In live oncology workflows at tier-1 cancer centers:
These results align with enterprise contract thresholds and measurable ROI.
Hurone operationalizes predictive risk models informed by validated research and millions of longitudinal patient records:
This creates a compounding data moat that grows with adoption.
Interested cancer centers can request a demo or connect with our enterprise team to discuss:
We tailor solutions to each institution’s care model and goals.
The name Hurone reflects our mission: to explore, uncover, and connect valuable signals in healthcare that are often unseen, enabling better outcomes.
The patient-facing application built on this platform is called Hurona.
Patients using Hurona through their health system can access support via their care team or the in-app help feature. For general questions, visit our Contact page or email support@hurone.ai.
Yes.
Hurone captures structured artifacts and time data relevant to:
This supports sustainable care delivery and helps justify investment in navigation infrastructure.
Hurone serves three audiences:
R & D Strategy Fellow, Hurone AI
Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition.
With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya.
Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.
Head of Communications
Head of Communications at Hurone AI, where she leads brand strategy, corporate communications, and strategic storytelling. With over 15 years of experience building social impact and CSR programs for global technology companies, Lisette specializes in aligning business strategy with meaningful community engagement.
Previously, Lisette held senior leadership roles at Amazon and Malwarebytes. At Amazon, she led global supplier education and social impact communications, scaling AI-enabled workflows, increasing supplier engagement by 200% year-over-year, and driving measurable ROI across complex international stakeholder environments. At Malwarebytes, she launched the company’s first corporate social impact program, secured national media coverage including NBC, and increased press reach by over 50% year-over-year.
Lisette brings deep expertise in stakeholder management, media strategy, AI-enabled operations, and purpose-driven brand building, helping technology companies translate mission into measurable impact.